Basit öğe kaydını göster

dc.contributor.authorMutlu, Tuba
dc.contributor.authorOzoran, Emre
dc.contributor.authorGÜVEN, MEHMET
dc.contributor.authorGÜVEN, MEHMET
dc.contributor.authorTalu, Canan Kelten
dc.contributor.authorTrabulus, Didem Can
dc.date.accessioned2023-10-10T11:35:10Z
dc.date.available2023-10-10T11:35:10Z
dc.identifier.citationGÜVEN M., Ozoran E., Talu C. K., Trabulus D. C., Mutlu T., GÜVEN M., "An investigation of the relationship between matriptase-2 protein expression and histopathological data in breast cancer", HUMAN GENE, cilt.33, 2022
dc.identifier.issn2773-0441
dc.identifier.othervv_1032021
dc.identifier.otherav_15cef49e-d37d-48eb-8a77-3bc3f9504715
dc.identifier.urihttp://hdl.handle.net/20.500.12627/189780
dc.identifier.urihttps://doi.org/10.1016/j.humgen.2022.201074
dc.description.abstractBreast cancer is the most common cancer in females. Therefore, early recognition of the disease is essential. Matriptase-2, a member of the Type II Transmembrane Serine Proteases (TTSP) family, plays a role in various types of cancer (breast, prostate, etc.). The matriptase-2 level is thought to be related to patients' prognosis. This study used the tumor and the normal breast tissue samples from 21 female patients with breast cancer. The levels of matriptase-2 protein expression in the tumor and the normal tissues of the breast cancer patients and examined the relation with histopathological findings were analyzed. The matriptase-2 protein expression levels was determined using the Western Blot method. The matriptase-2 protein expression levels in the tumor tissues were significantly lower than in the normal tissues (p = 0,012). The matriptase-2 protein expression levels in the normal tissues of patients with nuclear grades I/II, histological grades I/II, clinical stages III/IV, presence of lymph nodes, and microcalcification were statistically significantly higher than the matriptase-2 protein expression levels tumor tissues (p = 0,0001 for all). The results of our study are in line with findings in the literature showing that the increase in matriptase-2 level is associated with a good prognosis. Decrease in the level of the matriptase-2 protein in the tumor tissues and the relationship of this decrease with poor prognosis suggests that matriptase-2 may play a role in limiting the development of breast tumors by the mobile and invasive nature of breast cancer cells. The matriptase-2 level may have a prognostic value in breast cancer patients.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTemel Bilimler
dc.subjectGenetik (klinik)
dc.subjectMoleküler Biyoloji
dc.subjectGenetik
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectTıbbi Genetik
dc.subjectYaşam Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectGENETİK VE KALITIM
dc.titleAn investigation of the relationship between matriptase-2 protein expression and histopathological data in breast cancer
dc.typeMakale
dc.relation.journalHUMAN GENE
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Temel Tıp Bilimleri Bölümü
dc.identifier.volume33
dc.contributor.firstauthorID4309817


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster